Uniphar (UPR.I, UPR ID)

  • 649.8
  • 273.0
  • 78.0

    Closing Price (c): 238.0

  • RATING 27/08/19


Company Profile

Uniphar is a diversified healthcare services business operating across three divisions: Commercial & Clinical (55% of group EBITDA 2020E), Product Access (19%) and Supply Chain & Retail (26%). Structural industry growth, proprietary digital platforms and expansion into new geographies underpin a strong organic growth outlook. There is also meaningful scope for bolt-on M&A, supported by a senior leadership team with deep experience across the healthcare services space. Management aims to double group EBITDA within five years (15% CAGR).

Major Shareholders%
ROI Health7.3
Sisk Family7.2
MacKenzie Financial Corp6.4
Polar Capital LLP6.1